246 related articles for article (PubMed ID: 25383506)
1. "AND" logic gate regulated pH and reduction dual-responsive prodrug nanoparticles for efficient intracellular anticancer drug delivery.
Bai L; Wang XH; Song F; Wang XL; Wang YZ
Chem Commun (Camb); 2015 Jan; 51(1):93-6. PubMed ID: 25383506
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
[TBL] [Abstract][Full Text] [Related]
3. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
4. Tumor-activated prodrug (TAP)-conjugated nanoparticles with cleavable domains for safe doxorubicin delivery.
Guarnieri D; Biondi M; Yu H; Belli V; Falanga AP; Cantisani M; Galdiero S; Netti PA
Biotechnol Bioeng; 2015 Mar; 112(3):601-11. PubMed ID: 25220931
[TBL] [Abstract][Full Text] [Related]
5. Targeted theranostic prodrugs based on an aggregation-induced emission (AIE) luminogen for real-time dual-drug tracking.
Yuan Y; Kwok RT; Zhang R; Tang BZ; Liu B
Chem Commun (Camb); 2014 Oct; 50(78):11465-8. PubMed ID: 25137179
[TBL] [Abstract][Full Text] [Related]
6. Yolk-shell hybrid nanoparticles with magnetic and pH-sensitive properties for controlled anticancer drug delivery.
Li S; Zheng J; Chen D; Wu Y; Zhang W; Zheng F; Cao J; Ma H; Liu Y
Nanoscale; 2013 Dec; 5(23):11718-24. PubMed ID: 24107975
[TBL] [Abstract][Full Text] [Related]
7. An NIR-triggered and thermally responsive drug delivery platform through DNA/copper sulfide gates.
Zhang L; Li Y; Jin Z; Yu JC; Chan KM
Nanoscale; 2015 Aug; 7(29):12614-24. PubMed ID: 26147639
[TBL] [Abstract][Full Text] [Related]
8. A prodrug strategy based on chitosan for efficient intracellular anticancer drug delivery.
Chen C; Zhou JL; Han X; Song F; Wang XL; Wang YZ
Nanotechnology; 2014 Jun; 25(25):255101. PubMed ID: 24896540
[TBL] [Abstract][Full Text] [Related]
9. Drug Delivery Nanoparticles with Locally Tunable Toxicity Made Entirely from a Light-Activatable Prodrug of Doxorubicin.
Schutt C; Ibsen S; Zahavy E; Aryal S; Kuo S; Esener S; Berns M; Esener S
Pharm Res; 2017 Oct; 34(10):2025-2035. PubMed ID: 28791550
[TBL] [Abstract][Full Text] [Related]
10. Efficient reduction and pH co-triggered DOX-loaded magnetic nanogel carrier using disulfide crosslinking.
Huang J; Xue Y; Cai N; Zhang H; Wen K; Luo X; Long S; Yu F
Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():41-51. PubMed ID: 25491958
[TBL] [Abstract][Full Text] [Related]
11. Dual responsive supramolecular nanogels for intracellular drug delivery.
Chen X; Chen L; Yao X; Zhang Z; He C; Zhang J; Chen X
Chem Commun (Camb); 2014 Apr; 50(29):3789-91. PubMed ID: 24519486
[TBL] [Abstract][Full Text] [Related]
12. The effect of molecular structure on the anticancer drug release rate from prodrug nanoparticles.
Ikuta Y; Koseki Y; Onodera T; Oikawa H; Kasai H
Chem Commun (Camb); 2015 Aug; 51(64):12835-8. PubMed ID: 26165183
[TBL] [Abstract][Full Text] [Related]
13. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
[TBL] [Abstract][Full Text] [Related]
14. Dual Stimuli-Responsive Nanoparticles for Controlled Release of Anticancer and Anti-inflammatory Drugs Combination.
Feng L; Wang Y; Luo Z; Huang Z; Zhang Y; Guo K; Ye D
Chemistry; 2017 Jul; 23(39):9397-9406. PubMed ID: 28489292
[TBL] [Abstract][Full Text] [Related]
15. Core cross-linked poly(ethylene glycol)-graft-Dextran nanoparticles for reduction and pH dual responsive intracellular drug delivery.
Lian H; Du Y; Chen X; Duan L; Gao G; Xiao C; Zhuang X
J Colloid Interface Sci; 2017 Jun; 496():201-210. PubMed ID: 28232293
[TBL] [Abstract][Full Text] [Related]
16. Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy.
Xu Z; Liu S; Kang Y; Wang M
Nanoscale; 2015 Mar; 7(13):5859-68. PubMed ID: 25757484
[TBL] [Abstract][Full Text] [Related]
17. Pillar[5]arene based supramolecular prodrug micelles with pH induced aggregate behavior for intracellular drug delivery.
Wang Y; Du J; Wang Y; Jin Q; Ji J
Chem Commun (Camb); 2015 Feb; 51(14):2999-3002. PubMed ID: 25598131
[TBL] [Abstract][Full Text] [Related]
18. Probe-inspired nano-prodrug with dual-color fluorogenic property reveals spatiotemporal drug release in living cells.
Xue X; Jin S; Zhang C; Yang K; Huo S; Chen F; Zou G; Liang XJ
ACS Nano; 2015 Mar; 9(3):2729-39. PubMed ID: 25688453
[TBL] [Abstract][Full Text] [Related]
19. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.
Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z
Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504
[TBL] [Abstract][Full Text] [Related]
20. A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapy.
Li SY; Liu LH; Jia HZ; Qiu WX; Rong L; Cheng H; Zhang XZ
Chem Commun (Camb); 2014 Oct; 50(80):11852-5. PubMed ID: 25145493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
